Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis
# Background Targeted therapy for cancer is becoming more frequent as the understanding of the molecular pathogenesis increases. Molecular testing must be done to use targeted therapy. Unfortunately, the testing turnaround time can delay the initiation of targeted therapy. # Objective To investigat...
Saved in:
| Main Authors: | Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith, Rhodri Saunders |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2023-06-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.77686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-Effectiveness Analysis of a Heart Failure Management System in the United States
by: Antonia Bosworth Smith, et al.
Published: (2025-03-01) -
Sternal-Wound Infections following Coronary Artery Bypass Graft: Could Implementing Value-Based Purchasing be Beneficial?
by: Dominique Brandt, et al.
Published: (2020-08-01) -
Validation of a Model Estimating the Budget Impact of Video Capsule Endoscopy for Surveillance of Crohn’s Disease in an Italian Center
by: Rhodri Saunders, et al.
Published: (2024-03-01) -
Circulating tumor DNA- and cancer tissue-based next-generation sequencing reveals comparable consistency in targeted gene mutations for advanced or metastatic non-small cell lung cancer
by: Weijia Huang, et al.
Published: (2025-04-01) -
Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients
by: Ieva Drejeriene, et al.
Published: (2024-12-01)